Latest News in Neuroendocrine Tumours

PRRT Program at L’Hôtel-Dieu de Québec

Une approche novatrice contre le cancer à l'Hôtel-Dieu de Québec « Une nouvelle approche médicale attire à Québec des Canadiens, et même des Américains, atteints d'une forme rare de cancer. Le traitement [...]

By |2018-06-19T15:58:17+00:00June 19th, 2018|News|Comments Off on PRRT Program at L’Hôtel-Dieu de Québec

PMPRB Patient Group Consultation Submission

Patient Groups send a strong message to the Federal Minister of Health: Patient voices must be heard. We ask the @CDNMinHealth to halt the review of drug prices and move to [...]

By |2018-05-07T18:28:10+00:00February 15th, 2018|News|Comments Off on PMPRB Patient Group Consultation Submission

Raising NET Cancer Awareness on World Cancer Day

CNETS Canada Montreal Support Group Leaders Donna Hillier, Daniel Opoku and volunteer Marie-Anne Risdon set up a kiosk at the Ceders Cancer Foundation - CEDARS CANSUPPORT WORLD CANCER DAY, providing [...]

By |2018-05-07T18:28:10+00:00February 6th, 2018|News|Comments Off on Raising NET Cancer Awareness on World Cancer Day

Dr. Suzanne Richter

It is with profound sadness that we share the news of the passing of Dr. Suzanne Richter, Medical Oncologist on the NET team at London Health Sciences Centre.  This is [...]

By |2018-05-07T18:28:11+00:00April 4th, 2017|News|Comments Off on Dr. Suzanne Richter

Thank you

Thank you to all our donors and volunteers! As we start anew into 2017, CNETS Canada would like to acknowledge and thank all our donors and volunteers for their generosity. [...]

By |2018-05-07T18:28:11+00:00February 15th, 2017|News|Comments Off on Thank you


Media Advisory “LET’S TALK ABOUT NETs” Campaign Shines Spotlight on Rare Cancer Toronto, ON – October 27, 2016 – Between 12,000 to 15,000 Canadians are estimated to have a rare [...]

By |2018-05-07T18:28:12+00:00October 27th, 2016|Awareness, News|Comments Off on “LET’S TALK ABOUT NETs”

ESMO 2016 NET News

Clinical benefit demonstrated with everolimus and pasireotide LAR alone or in combination in the first randomised, prospective study entirely dedicated to advanced lung and thymic carcinoids. In patients with advanced [...]

By |2018-05-07T18:28:12+00:00October 13th, 2016|Clinical Trial, News, Treatment News|Comments Off on ESMO 2016 NET News
Go to Top